$15.00

i 1.00 Hours

Course Overview

Radiotherapy is one of the primary interventions used to limit the progress of Hodgkin’s lymphoma (HL). Traditionally, chemotherapy with or without radiotherapy has been used to improve survival in patients. The decision to include radiotherapy in the treatment protocol for HL usually depends on the severity of the cancer at the time of diagnosis. Recently, studies following HL survivors for a longer duration after remission have found an increased occurrence of secondary malignant neoplasms and cardiovascular diseases. Such adverse effects lower the quality of life in surviving patients. Radiotherapeutic intervention in patients with HL should be implemented only after careful examination of patient parameters that necessitate this treatment strategy. Knowledge of risks and benefits of this intervention is helpful for recommending effective treatment plans.

About the Course Author

Olive Peart, MS, RT(R)(M), is a SME Writer with Relias. She is an established author, radiographer and educator with years of experience as a radiologic technology program director. She has authored several radiology and mammography related textbooks. She also volunteers with RAD-AID international and served as a program manager with the Asha Jyoti: Women's Healthcare Mobile Outreach Programme, Chandigarh, India and currently serves as RAD-AID's Chief Mammography Technologist for the RAD-AID USA Women's Health Initiative.

Olive Peart, MS,RT(R)(M) has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!


Become a member today and enjoy instant savings on all courses

Accreditation Information

Certificates provided by accrediting body (2 Match)

  • American Society of Radiologic Technologists

    1.00HOURS

    This activity is approved for credit by the American Society of Radiologic Technologists (ASRT) until 5/1/2022.
    Approved by the ASRT for Category A continuing education credit
    This activity may be available in multiple formats or from different sponsors. ASRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium.
  • Mississippi State Department of Health Bureau of Professional Licensure Medical Radiation Technologists

    1.00HOURS

    Mississippi State Department of Health Bureau of Professional Licensure Medical Radiation Technologists (CEBroker Provider #50-290).
    Radiation technologists will receive 1.0 contact hours for participating in this course.


Course Details
  • Course Code:

    REL-ACU-0-RAD07
  • Hours:

    1.00
  • Type:

    Online Course
  • Release Date:

    2020-05-01
  • Expiration Date:

    2023-04-30
  • Learning Objectives:

    Describe the evidence supporting the use of radiotherapy in treating Hodgkin’s lymphoma.; Discuss the adverse effects associated with radiotherapy.; Identify patients in whom radiotherapy will improve survival.
  • Target Audience:

    The target audience for this course is: Radiologic Technologists; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.